Syndax Pharmaceuticals Inc
SNDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395937
In the last 90 days, Syndax Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 242 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Syndax Pharmaceuticals Inc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 196
- +8 vs. Q1 2024
- Shares held
- 87.4M
- −2.85M (−3.2%) vs. Q1 2024
- Total value
- $1.79B
- −$353.3M (−16.5%) vs. Q1 2024
- New holders
- 26
- 87 more added
- Sold out
- 18
- 59 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 242 | $2.36B |
| Q1 2026 | 247 | $2.32B |
| Q4 2025 | 230 | $2.10B |
| Q3 2025 | 227 | $1.56B |
| Q2 2025 | 217 | $952.6M |
| Q1 2025 | 219 | $1.24B |
| Q4 2024 | 216 | $1.30B |
| Q3 2024 | 210 | $1.71B |
| Q2 2024 | 196 | $1.79B |
| Q1 2024 | 189 | $2.15B |
| Q4 2023 | 177 | $1.92B |
| Q3 2023 | 175 | $1.03B |
| Q2 2023 | 166 | $1.48B |
| Q1 2023 | 163 | $1.54B |
| Q4 2022 | 160 | $1.82B |
| Q3 2022 | 139 | $1.44B |
| Q2 2022 | 121 | $1.06B |
| Q1 2022 | 136 | $948.4M |
| Q4 2021 | 132 | $1.15B |
| Q3 2021 | 123 | $938.0M |
| Q2 2021 | 115 | $861.9M |
| Q1 2021 | 130 | $1.08B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Syndax Pharmaceuticals Inc; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −55,297−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −38,832−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −30,760−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −23,520−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −21,519−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −17,033−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −16,590−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −15,523−100.0% | Sold out |
| Principle Wealth Partners LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Clear Harbor Asset Management, LLC | 0 | $0 | 0.00% | −8,956−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −4,150−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −218−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |